Skip navigation.
Home
Last Updated: Saturday 22 November 2008 09:47 GMT | [Write for us] | [Subscribe to RSS] | [Advertise with us] [Editor's Blog]

FDA Panel Backs Roche’s Rheumatoid Arthritis Drug

FDA Panel Backs Roche’s Rheumatoid Arthritis Drug

Despite safety concerns about how the treatment will affect the liver, a panel of medical experts, on Tuesday, voted 10-1 vote for Swiss manufacturer, Roche Holding AG's rheumatoid arthritis drug, Actemra.

In an 11 member panel, 10 members voted in favor of recommending approval, while one voted against the idea.

Though it is not mandatory for the U.S. Food and Drug Administration, who sponsored the panel, to follow its recommendations, but it invariably does so. FDA’s final decision on whether to approve the drug or not is expected by September 18.

Effective in treating rheumatoid arthritis, or RA, in adults - a progressive joint damaging disease that can lead to disability – Actemra blocks interleukin-6 (IL-6), an immune-system protein the spurs inflammation. A highly painful condition, in severe cases the disorder can destruct other organs including the lungs and skin.

Conversely, other widely used drugs block a protein called tumor necrosis factor (TNF).

Though the drug’s ability to relieve symptoms outweighed the potential risks, members on panel urged regular monitoring of patients' liver function and cholesterol levels, as laboratory tests of the drug showed elevated liver enzymes and increased LDL or "bad" cholesterol in some patients.

"The safety concerns are real, and I think there is going to have to be monitoring," said panel member Dr. David Felson, clinical epidemiology chief at Boston University School of Medicine.

We appreciate your comments

Please solve the math problem above and type in the result. e.g. for 1+1, type 2
The content of this field is kept private and will not be shown publicly.

Subscribe to RSS Feeds Subscribe for free via email, or grab our feed.
 

Recent comments

Cancerdefine is one of the most potent diseases and claims millions of lives around the globe every year. Certain kinds of cancer typically affect women only. Here’s themedguru’s low-down on these lady-killers…

Cancers in Women

A cancerdefine is a state of abnormal growth and replication of cells in the body at a certain point. The cell division is a highly regulated process with the new cells getting formed only when the old cells die. However, this process can go off track at times with the continuous growth of new cells at a rate higher than the cell death rate. Thus, the extra cell mass is formed in a tissue or an organ which is called a tumor.

    Heart attack is one of the major causes of women’s death after breast cancerdefine and poses a great threat to women. At least one in three women dies of heart disease or stroke. The fact is that women are as much vulnerable to a heart attack as men.

    Heart-attack in Women – A Silent Killer

    While heart disease becomes significantly prevalent among women after they reach menopause, it can and does affect younger women too. According to the American Heart Association, heart disease kills about 16,000 young women and accounts for 40,000 hospitalizations in young women in U.S. every year. So, women of all ages need to become aware of it and take steps to prevent heart disease.

      Diabetes has a unique impact on the lives of adolescents and requires constant monitoring of blood sugar levels, medication and effects of food and activity. With careful management by diabetologists, nutritionists, and psychologists, and with support from parents, these young people can lead full and healthy lives.

      With proper care, adolescent diabetics can lead full and healthy lives

      The International Diabetes Federation (IDF)’s World Diabetes Day campaign focuses this year on children and adolescents with diabetes. According to IDF, children and adolescents with diabetes face a lifetime of living with a disease that poses particular challenges for them. These struggles include higher insulindefine insensitivity linked to puberty, rapid behavioural changes, increased risk of depressiondefine, anxiety, and low self-esteem and transition to adult services.